ConductScience.org, home

Library / Trials

Active Versus Passive Sitting, Cognition and Energy

NCT07699848, Not applicable, Recruiting, University of Miami

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleActive Versus Passive Sitting, Cognition and EnergyClinicalTrials.gov
NCT numberNCT07699848ClinicalTrials.gov
StatusRecruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment35 participants, estimatedClinicalTrials.gov
Lead sponsorUniversity of MiamiClinicalTrials.gov
ConditionsElectromyography, Pressure Injury of BackClinicalTrials.gov
InterventionsChaircise, Chaircise + Dynamic Leg Exercise, Chaircise + Static Leg ExerciseClinicalTrials.gov
First posted2026-07-13ClinicalTrials.gov
Last updated2026-08-20ClinicalTrials.gov

Registered outcomes 6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryDifferences in cognitive performance among chair conditions as measured by the Psychomotor Vigilance Test in number of key depressionsApproximately 3 minutes
Cognitive performance will be assessed using the 3-minute Psychomotor Vigilance Test (PVT). During the test, participants will press the space bar as quickly as possible in response to the appearance of a visual stimulus on a computer screen. Performance will be measured as the total number of valid responses recorded during the test. Higher values indicate greater alertness, sustained attention, and reaction speed.
ClinicalTrials.gov
PrimaryExecutive function among chair conditions as measured by the Stroop Test using words counted.Approximately 5 minutes.
Executive function will be assessed using the Stroop Test, a cognitive task requiring participants to respond to color word stimuli. The outcome will be measured by total words counted, reported as the number of words.
ClinicalTrials.gov
PrimaryExecutive function among chair conditions as measured by the Stroop Test using error rate.Approximately 5 minutes.
Executive function will be assessed using the Stroop Test, a cognitive task requiring participants to respond to color word stimuli. The outcome will be measured by error rate, reported as the percentage of errors.
ClinicalTrials.gov
PrimaryMuscle activity among chair conditions using electromyographyApproximately 45 minutes
Muscle activity will be assessed using surface electromyography (EMG). Muscle activation will be quantified as EMG amplitude, measured in microvolts (µV) from EMG recordings. Higher values indicate greater muscle activity.
ClinicalTrials.gov
PrimaryPeak seated tissue pressure among chair conditions using a pressure sensitive matApproximately 15 minutes
Seated tissue pressure will be assessed using a pressure-sensitive mat placed on the seat surface of each chair. Peak pressure will be recorded to quantify the highest pressure exerted at the seating interface during each chair condition, measured in kilopascals. Higher values indicate greater localized pressure on seated tissues.
ClinicalTrials.gov
PrimaryMetabolic cost of sitting among the chair conditions using a portable oxygen consumption unitApproximately 25 minutes
Metabolic cost during sitting will be assessed under each chair condition using a portable indirect calorimetry device. Participants will wear a facemask that measures oxygen consumption (VO₂) and carbon dioxide production (VCO₂). These measurements will be used to estimate energy expenditure during the sitting period. Higher values indicate greater metabolic cost.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Psychomotor Vigilance TaskPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)